Home »
Academic Articles & Research Papers
Showing 12 of 12 academic articles
Nakazawa S, Sakai K, Fukai K, Furuya Y et al. • BMC public health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12889-026-28932-7
PMC: PMC13729562
Chappell CA, Stewart E, Laird HJ, Jonassaint N et al. • Journal of addiction medicine
(2024)
PMC
PMC Public Access (View-Only)
DOI: 10.1097/ADM.0000000000001266
PMC: PMC13735479
Kohlmaier B, Indolfi G, Baumann U, Gonçalves C et al. • Journal of pediatric gastroenterology and nutrition
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/jpn3.70543
PMC: PMC13736125
Xie C, Wang B, Wang Y, Zhao G et al. • Journal of veterinary science
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.4142/jvs.25210
PMC: PMC13655562
Saxena R, Varshney S, Khan MS, Bansal M et al. • Cureus
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.7759/cureus.117388
PMC: PMC13726377
Nick Bansback, Mina Tadrous, Marie Paul Nisingizwe, Michael R Law et al. • BMJ Public Health
(2025)
Background The introduction of direct-acting antivirals (DAAs) has allowed countries to reduce the health and economic burden of hepatitis C virus (HCV). However, access to DAAs remains expensive and limited in many countries globally due t...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/bmjph-2024-001340
Samara Griffin, Timothy Papaluca, Jacinta A Holmes, Bridget Reid et al. • Health & Justice
(2026)
Abstract Background The community corrections population in Australia shares similar risk factors for hepatitis C virus (HCV) infection with people incarcerated in prisons, but without access to prison-based testing and treatment. While hep...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s40352-026-00411-6
S Yu Milovanova, L V Lysenko (Kozlovskaya), L Yu Milovanova, N N Mrykhin et al. • Терапевтический архив
(2018)
Hepatitis C virus (HCV) is a global population problem due to its high prevalence, usually late diagnosis, the difficulties of treatment. In the prognosis of patients with HCV not only hepatic, but increasingly frequent of extrahepatic HCV ...
DOAJ
Open Access (DOAJ)
DOI: 10.26442/terarkh2018906112-120
Hui Jun Zhou, Jing Cao, Hui Shi, Nasheen Naidoo et al. • Frontiers in Public Health
(2021)
Background: Hepatitis C virus (HCV) genotype 1 is the most prevalent HCV infection in China. Sofosbuvir-based direct antiviral agent (DAA) regimens are the current mainstays of treatment. Sofosbuvir/velpatasvir (SOF/VEL) and sofosbuvir/ledi...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fpubh.2021.779215
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin et al. • Frontiers in Immunology
(2022)
Hepatocellular carcinoma(HCC) is the sixth most common cancer in the world and is usually caused by viral hepatitis (HBV and HCV), alcoholic, and non-alcoholic fatty liver disease(NAFLD). Viral hepatitis accounts for 80% of HCC cases worldw...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2022.984728
Raife Dilek Turan, Cihan Tastan, Derya Dilek Kancagi, Bulut Yurtsever et al. • Scientific Reports
(2021)
Abstract The SARS-CoV-2 virus caused the most severe pandemic around the world, and vaccine development for urgent use became a crucial issue. Inactivated virus formulated vaccines such as Hepatitis A and smallpox proved to be reliable appr...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-021-95086-4
Mamun Al-Mahtab, Salimur Rahman, Fazal Karim, Graham Foster et al. • Bangabandhu Sheikh Mujib Medical University Journal
(2009)
Background: Hepatitis C virus is encountered sporadically in Bangladesh. It results in a wide range liver diseases, with asymptomatic acute hepatitis rarely at one end to HCC at the other end of the spectrum.
Methods: 1018 individuals of ...
DOAJ
Open Access (DOAJ)
DOI: 10.3329/bsmmuj.v2i1.3705